NanoViricides, Inc. (NNVC)

NYSEAMERICAN: NNVC · USD

$1.44

-0.02 (-1.4%)· Recorded snapshot

Market cap	36.8M
Net income (ttm)	-8.2M
EPS (ttm)	-$0.41
Shares out	25.5M
Volume	81,654
Beta	1.79

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -8.2M
EPS (ttm): -$0.41
Market cap: 36.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-101.5

P25 n/aP50 n/aP75 n/a

ROIC-64.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All NNVC indicators

Market & fundamental data

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001379006
Company name	NanoViricides, Inc.
Country	United States
Country code	US
CUSIP number	630087302
Earnings date	2026-11-13
Earnings time	amc
Employees	7
Employees change	0
Employees growth	0%
Enterprise value	$34M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	2005
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US6300873022
Last 10-K release date	2026-09-28
Last earnings date	2026-09-28
Last refreshed	2026-10-28
Last stock split date	2019-09-24
Last stock split type	Reverse
Market cap	$36.8M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	Yes
Price	$1.44
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	NNVC
U.S. state	Connecticut
Website	https://www.nanoviricides.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-28.27%
FCF / EV yield	-22.57%
FCF yield	-20.88%
P/B ratio	3.87x
Price / tangible book value	4.45x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-1.2M
ROA	-55.53%
ROA (5Y)	-38.65%
ROCE	-95.66%
ROE	-101.46%
ROE (5Y)	-68.01%
ROIC	-64.09%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	7
EPS growth years	3
Net income growth years	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-84,317
Depreciation and amortization	$525,286
EBIT	$-8.3M
EBITDA	$-7.8M
EPS	$-0.41
FCF per share	$-0.30
Financing cash flow	$9M
Free cash flow	$-7.8M
Free cash flow minus SBC	$-8.1M
Investing cash flow	$-84,317
Net cash flow	$1.2M
Net income	$-8.2M
Operating cash flow minus SBC	$-8.1M
Operating income	$-8.3M
Stock-based compensation	$367,955

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.38
Debt / equity	0
Long-term assets	$6.7M
Long-term liabilities	$0
Net cash (debt)	$2.8M
Net cash / market cap	7.5%
Net cash growth	79.27%
Net debt / equity	-0.32
Piotroski F-Score	2
Property, plant and equipment	$6.4M
Shareholders' equity	$8.7M
Tangible book value	$8.4M
Tangible book value per share	$0.36
Total assets	$9.9M
Total cash	$2.8M
Total debt	$0
Total liabilities	$1.2M
WACC	14.1%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$3.2M
Current liabilities	$1.2M
Current ratio	2.66
Net working capital	$-822,211
Quick ratio	2.35
Working capital	$2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-33.55%
Dividend yield	0%
Shareholder yield	-33.55%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-95.1%
10Y return CAGR	-26.05%
10Y total return	-95.1%
150-day SMA	$1.37
15Y price change	-97.96%
15Y return CAGR	-22.84%
15Y total return	-97.96%
1D price change	-1.37%
1M price change	1.39%
1M total return	1.39%
1W price change	-1.35%
1W total return	-1.35%
1Y price change	-9.32%
1Y return CAGR	-9.32%
1Y total return	-9.32%
20-day SMA	$1.37
200-day SMA	$1.29
20Y price change	-98.17%
20Y return CAGR	-18.13%
20Y total return	-98.17%
3M price change	-5.19%
3M total return	-5.19%
3Y price change	21.67%
3Y return CAGR	6.75%
3Y total return	21.67%
50-day SMA	$1.31
50-day SMA vs 200-day SMA	50over200
52-week high	$2.23
52-week high date	2025-11-05
52-week low	$0.85
52-week low date	2026-02-05
5Y price change	-70.14%
5Y return CAGR	-21.48%
5Y total return	-70.14%
6M price change	16.8%
6M total return	16.8%
All-time high	$262.50
All-time high date	2006-03-21
All-time low	$0.85
All-time low date	2026-02-05
Average true range (ATR)	$0.11
Average volume	236.4K
Beta (1Y)	2.11
Beta (2Y)	0.97
Beta (5Y)	1.79
Change from 52-week high	-35.43%
Change from 52-week low	69.41%
Change from all-time high	-99.44%
Change from all-time low	71.76%
Change from open	-2.37%
Day's gap	1.03%
Dollar volume	$117,582
High price	$1.49
Low price	$1.44
Monthly RSI	50.59
Open price	$1.48
Position in 52-week range	0%
Premarket change	1.49%
Premarket close	$1.46
Premarket price	$1.48
Premarket volume	3.5K
Previous close	$1.46
Price vs 150-day SMA	6.41%
Price vs 20-day SMA	6.34%
Price vs 200-day SMA	13.35%
Price vs 50-day SMA	11.11%
Relative volume	0.35
RSI	55.45
Sharpe ratio	0.31
Sharpe ratio (3Y)	0.49
Sharpe ratio (5Y)	0.13
Sortino ratio	0.61
Sortino ratio (3Y)	0.86
Sortino ratio (5Y)	0.29
Volume	81.7K
Weekly RSI	53.79
YTD price change	29.2%
YTD total return	29.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	24.9M
Float percentage	97.51%
Shares change (QoQ)	2.99%
Shares change (YoY)	33.55%
Shares held by insiders	0.64%
Shares held by institutions	9.42%
Shares outstanding	25.5M
Short % of float	3.72%
Short % of shares	3.63%
Short ratio	1.4 days

Deeper analysis on NNVC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this NNVC report

Is a complete NNVC research report available?

No complete published report is available for NanoViricides, Inc. (NNVC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NanoViricides, Inc. (NNVC)

Price

Financial snapshot

Fair-value bridge

Latest news · NNVC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NNVC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NNVC

Frequently asked questions